SunTrust Reiterates Buy Rating for Medidata Solutions (MDSO)
Medidata Solutions (NASDAQ:MDSO)‘s stock had its “buy” rating reaffirmed by equities researchers at SunTrust in a research report issued on Wednesday, AnalystRatingsNetwork reports. They currently have a $50.00 price objective on the stock. SunTrust’s price objective would suggest a potential upside of 25.72% from the stock’s previous close.
Medidata Solutions (NASDAQ:MDSO) traded down 3.21% on Wednesday, hitting $39.77. The stock had a trading volume of 1,422,230 shares. Medidata Solutions has a 1-year low of $29.025 and a 1-year high of $68.21. The stock’s 50-day moving average is $54.54 and its 200-day moving average is $57.18. The company has a market cap of $2.072 billion and a P/E ratio of 234.80.
Medidata Solutions (NASDAQ:MDSO) last issued its quarterly earnings data on Tuesday, April 22nd. The company reported $0.11 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.16 by $0.05. The company had revenue of $76.60 million for the quarter, compared to the consensus estimate of $79.50 million. During the same quarter last year, the company posted $0.18 earnings per share. Medidata Solutions’s revenue was up 21.0% compared to the same quarter last year. On average, analysts predict that Medidata Solutions will post $0.75 earnings per share for the current fiscal year.
A number of other analysts have also recently weighed in on MDSO. Analysts at Citigroup Inc. reiterated a “buy” rating on shares of Medidata Solutions in a research note on Wednesday. They now have a $53.00 price target on the stock. Separately, analysts at Deutsche Bank reiterated a “buy” rating on shares of Medidata Solutions in a research note on Wednesday. They now have a $57.00 price target on the stock, down previously from $67.00. Finally, analysts at Jefferies Group reiterated a “buy” rating on shares of Medidata Solutions in a research note on Wednesday. They now have a $50.00 price target on the stock, down previously from $72.50. Two analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Medidata Solutions currently has an average rating of “Buy” and an average price target of $59.95.
Medidata Solutions, Inc (NASDAQ:MDSO) is a global provider of software-as-a-service (SaaS), clinical technology solutions.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.